On June 11, 2015, the New York Times reported that a small Chinese company had produced 100 doses of an Ebola drug that closely mirrored a drug patented by a U.S. drug-maker and for which the U.S. government held a patent on one of the constituent antibodies. According to the article, a U.S. government official […]
Posts Tagged ‘China’
This session broadly addressed the development of IP law in China, focusing in particular on how Chinese bureaucrats and judges approach “the rule of law”; the difficulties and opportunities faced by Western companies seeking to protect their IP in China; and the strategies of Chinese regulators to create an IP regime consistent with parochial economic […]
The Fordham IP Institute and the Chinese Business Lawyers Association hosted a delegation of distinguished Chinese IP professionals at Fordham Law School on September 19, 2014. The Chinese delegation was comprised of high-level government officials including representatives from the Supreme People’s Court and the Ministry of Commerce. The delegation was also joined by U.S. practitioners […]
On October 29, 2013 Mark Cohen, former Fordham law professor and now Senior Counsel, China, USPTO, spoke about “China, IP and the World” at a luncheon for IP Institute sponsors.
On January 28, 2013 Fordham and Jones Day sponsored a one-day conference on Biotech & Pharmaceutical Issues in China, which explored current topics in one of the hottest growth sectors within one of the world’s dominant economies. AGENDA 8:50–9 a.m Opening Comments Sheila Foster, Vice Dean, Fordham Law 9–10 a.m. WHERE ARE PHARMA AND BIOTECH […]
On January 10, 2013 Fordham and GW Law co-sponsored a one-day conference in Washington, D.C., entitled China’s Patent Regime and its Quest to Become an Innovation Economy. AGENDA 9:30 – 10:30am: Keynote Speaker Chief Judge Randall R. Rader 11am – 12:30pm: “Challenges Facing China’s New Leadership” Overview of Patenting Trends and Enforcement Developments Innovation Policies from the […]